In this episode, ACD/Labs Vice President of Innovation and Informatics Strategy, Andrew Anderson, and Strategic Partnerships Director, Graham McGibbon continue their discussion on digitalization and digital transformation in the context of pharmaceutical R&D. They assess how well the industry is adapting to the current digital landscape, and what can be done to contribute to the overall digitalization process.Andrew and Graham also share their thoughts on how digitalization can be used al...
All content for The Analytical Wavelength is the property of ACD/Labs and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, ACD/Labs Vice President of Innovation and Informatics Strategy, Andrew Anderson, and Strategic Partnerships Director, Graham McGibbon continue their discussion on digitalization and digital transformation in the context of pharmaceutical R&D. They assess how well the industry is adapting to the current digital landscape, and what can be done to contribute to the overall digitalization process.Andrew and Graham also share their thoughts on how digitalization can be used al...
A SMASHing Conference - Updates from the World of NMR
The Analytical Wavelength
20 minutes
3 years ago
A SMASHing Conference - Updates from the World of NMR
The last couple of years have been extremely disruptive. Covid-19 even influenced the world of chemistry - scientists changed the way they worked, and conferences moved online.With conferences and trade shows coming back, now is the perfect time to check-in on the field of NMR. Are things returning to normal, or have we shifted to a new normal?Dimitris Argyropoulos and Mary McKee join the podcast to share their experiences at SMASH. They provide insights about the evolving role of conferences...
The Analytical Wavelength
In this episode, ACD/Labs Vice President of Innovation and Informatics Strategy, Andrew Anderson, and Strategic Partnerships Director, Graham McGibbon continue their discussion on digitalization and digital transformation in the context of pharmaceutical R&D. They assess how well the industry is adapting to the current digital landscape, and what can be done to contribute to the overall digitalization process.Andrew and Graham also share their thoughts on how digitalization can be used al...
